ERG and OCT abnormalities in retinoblastoma after melphalan intravitreous injection
2021

Retinal Toxicity from Melphalan in Retinoblastoma Treatment

Sample size: 1 publication Evidence: moderate

Author Information

Author(s): Marina L. de Albuquerque, Renata Moreto, Maristella Bergamo, Zélia M. Corrêa, Rodrigo Jorge

Primary Institution: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo

Hypothesis

Does intravitreal melphalan cause retinal toxicity in children with retinoblastoma?

Conclusion

Intravitreal melphalan can lead to significant retinal toxicity, affecting vision despite its therapeutic benefits.

Supporting Evidence

  • Melphalan toxicity is dose-dependent and can affect vision.
  • After treatment, the child showed retinal pigment epithelial changes and decreased electroretinogram responses.
  • Optical coherence tomography revealed loss of photoreceptors and outer nuclear layers.

Takeaway

A little girl received a treatment for eye cancer, but it made her retina sick, which could hurt her vision.

Methodology

The study involved full-field electroretinogram and optical coherence tomography assessments after intravitreal melphalan injections.

Limitations

The effects of other treatments on retinal function were not isolated.

Participant Demographics

An 18-month-old girl with unilateral group D retinoblastoma.

Digital Object Identifier (DOI)

10.5935/0004-2749.2021-0037

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication